SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001048462-09-000006
Filing Date
2009-02-09
Accepted
2009-02-09 13:07:25
Documents
1
Group Members
CHARLES E. DAVIDSONJOSEPH M. JACOBSTHETA INVESTORS LLCWEXFORD SPECTRUM INVESTORS LLC

Document Format Files

Seq Description Document Type Size
1 WEXFORD CAPITAL SC13GA2 02-09-09 formsc13ga2.htm SC 13G/A 196706
  Complete submission text file 0001048462-09-000006.txt   198893
Mailing Address 125 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140
Business Address 125 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140 617-349-4500
JAVELIN PHARMACEUTICALS, INC (Subject) CIK: 0000050710 (see all company filings)

IRS No.: 880471759 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-62367 | Film No.: 09580405
SIC: 2834 Pharmaceutical Preparations

Mailing Address 411 W PUTNAM AVENUE GREENWICH CT 06830
Business Address 411 W PUTNAM AVENUE GREENWICH CT 06830 2038627000
WEXFORD CAPITAL LLC (Filed by) CIK: 0001048462 (see all company filings)

IRS No.: 061442624 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A